Skip to main content

Table 3 Clinical outcomes

From: Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival

  2-year rates 5-year rates
Overall survival 65.7% 50.8%
Bladder cancer specific survival 77.3% 67.3%
Survival with intact bladder* 64.2% 49.0%
Local-regional control 69.8% 61.7%
Distant-metastasis-free survival 73.5% 67.1%
Progression-free survival 51.9% 39.9%
  1. *Only one patient with local failure received radical cystectomy as salvage treatment.